
|Slideshows|September 10, 2019
- Drug Topics September 2019
- Volume 163
- Issue 9
Support Staff Training Resources
Author(s)Fred Gebhart
Advertisement
Articles in this issue
about 6 years ago
Biosimilars: Some Call for ‘Cautious Optimism’about 6 years ago
Biosimilars Need Access and Cost Examinationsabout 6 years ago
The Latest Autoimmune Disease Treatment Advancesabout 6 years ago
Unique Offerings Increasing Revenueabout 6 years ago
The Growing Problem of Pharmacy Desertsabout 6 years ago
What is a Pharmacy Desert?about 6 years ago
Patient Services are Crucial to the Economics of Pharmacyabout 6 years ago
New Video Marketing Toolsabout 6 years ago
Antimicrobial Stewardship: Protecting Global HealthNewsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
How the Delinking Model Can Drive Transparency, Avoid PBM Manipulation | NCPA 2025
2
PCV21 Shows Cost Effectiveness Compared With PCV15, PCV13, and PPSV23
3
Providers, Patients Show Favorable Perception of Remdesivir During COVID-19 Pandemic
4
Pharmacies Should Be Proactive in Expanding Clinical Services, Reimbursement Pathways | NCPA 2025
5


























































































































































